Longitudinal Study of Patients with Connective Tissue Disease–Interstitial Lung Disease and Response to Mycophenolate Mofetil and Rituximab
<b>Background/Objective:</b> To investigate the effect of mycophenolate mofetil (MMF) and rituximab (RTX) on pulmonary function test (PFT) results in a mixed cohort of patients with connective tissue disease-associated interstitial lung disease (CTD-ILD), longitudinally followed up for 1...
Saved in:
| Main Authors: | Yan Li, Sehreen Mumtaz, Hassan Z. Baig, Isabel Mira-Avendano, Benjamin Wang, Carlos A. Rojas, Justin T. Stowell, Elizabeth R. Lesser, Shalmali R. Borkar, Vikas Majithia, Andy Abril |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/14/23/2702 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01) -
Full recovery over one year of the overlap syndrome scleromyositis to maintenance therapy with mycophenolate mofetil and rituximab, which relapsed within 8 months of discontinuation
by: Inês Amarante, et al.
Published: (2025-05-01) -
Prognostic significance of acute exacerbations and usual interstitial pneumonia in fibrotic interstitial lung disease
by: Yun Zhang, et al.
Published: (2025-07-01) -
Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease
by: Hyung Koo Kang, et al.
Published: (2025-07-01) -
Use of rituximab in connective tissue disease-associated interstitial lung disease: a narrative review
by: Chenhao Xu, et al.
Published: (2025-05-01)